Company intelligence / Profile preview
The Chemo-Sero-Therapeutic Research Institute
Kumamoto, Kumamoto, Japankaketsuken.or.jp ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Kaketsuken was a leading Japanese foundation specializing in the research, development, manufacture and supply of vaccines for humans and animals as well as blood plasma derivatives. It played a pivotal role in Japan’s public health through vaccine innovation and partnerships with major pharmaceutical companies. In recent years before its business transfer to KM Biologics in April 2018,[10] it had approved products such as DTaP-hepatitis B vaccine and H5N1 influenza vaccine.[7] It also contributed significantly to the eradication of diseases like smallpox and rabies in Japan.[8]
- Therapeutic areas
- RheumatologyInfectious Diseases
- Modalities
- Vaccines (human and animal)Blood plasma derivatives[4]
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Daiichi Sankyo (cooperative sales agreements for vaccines until March/April of respective years)[9]Takeda Pharmaceuticals (collaborations on flu shots & other products)[2][3]VaxGen Inc. (smallpox/monkeypox vaccines development partnership)[4]
Beyond the preview
Go deeper on The Chemo-Sero-Therapeutic Research Institute.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on The Chemo-Sero-Therapeutic Research Institute.